NEW YORK (GenomeWeb News) – Brooks Automation said that it has completed its $79 million acquisition of automated compound and sample management solution company Nexus Biosystems.
Based in Poway, Calif., Nexus' offerings include systems for sample management, storage, and retrieval, microplates, and products for protein crystallization.
Brooks is headquartered in Chelmsford, Mass., and provides automation, vacuum, and instrumentation solutions. In a statement, Steve Schwartz, president and CEO of Brooks, said that he plans to build the company into "the market and innovation leader in biobanking and compound sample management.
"With Nexus' operations on the West Coast and meaningful sales and service locations in Switzerland, Japan, and Germany complementing our existing life science systems' direct present on the East Coast and in the UK, we will have broad global reach," he said.
Nexus was formed in 2005 by the buy-out of certain assets from Discovery Partners, and its customers include the genomics, pharmaceutical, biotechnology, and biorepository industries. Last year, it acquired Remp, a supplier of automated systems for the life science industry, as well as the sample management business of Tecan. In 2009 it bought microplate firm Aurora Biotechnologies.